• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

支气管肺发育不良(BPD)和极早产儿患者的终生预后和医疗保健利用:一项微观模拟研究。

Lifetime patient outcomes and healthcare utilization for Bronchopulmonary dysplasia (BPD) and extreme preterm infants: a microsimulation study.

机构信息

Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON, Canada.

School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.

出版信息

BMC Pediatr. 2020 Mar 25;20(1):136. doi: 10.1186/s12887-020-02037-5.

DOI:10.1186/s12887-020-02037-5
PMID:32213174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7093972/
Abstract

BACKGROUND

Bronchopulmonary dysplasia (BPD) is among the most severe chronic lung diseases and predominantly affects premature infants. There is a general understanding of BPD's significant impact on the short-term outcomes however there is little evidence on long-term outcomes. Our study estimates the lifetime clinical outcomes, quality of life, and healthcare costs of BPD and associated complications.

METHODS

We developed a microsimulation model to estimate lifetime clinical and economic burden of BPD among extreme preterm infants (≤28 weeks gestational age at birth) and validated it against the best available Canadian data. We further estimate the cumulative incidence of major complications associated with BPD, differentiated by BPD severity and gestational age category.

RESULTS

We find, on average, patients with BPD and resulting complications will incur over CAD$700,000 in lifetime health systems costs. We also find the average life expectancy of BPD patients to be moderately less than that of the general population and significant reductions in quality-adjusted life year due to major complications. Healthcare utilization and quality of life measures vary dramatically according to BPD severity, suggesting significant therapeutic headroom for interventions that can prevent or mitigate the effects of BPD for patients.

CONCLUSIONS

Our study adds a significant expansion of existing evidence by presenting the lifetime burden of BPD based on key patient characteristics. Given the extreme cost burden at the earliest stage of life and lifetime negative impact on quality of life, there is larger headroom for investment in prevention and mitigation of severe BPD than is currently available.

摘要

背景

支气管肺发育不良(BPD)是最严重的慢性肺部疾病之一,主要影响早产儿。人们普遍了解 BPD 对短期结局的重大影响,但对长期结局的证据甚少。我们的研究估计了 BPD 及其相关并发症的终身临床结局、生活质量和医疗保健成本。

方法

我们开发了一个微观模拟模型,以估计极早产儿(出生时胎龄≤28 周)中 BPD 的终身临床和经济负担,并根据加拿大最佳现有数据对其进行了验证。我们进一步估计了与 BPD 相关的主要并发症的累积发生率,并按 BPD 严重程度和胎龄类别进行了区分。

结果

我们发现,平均而言,患有 BPD 及其相关并发症的患者将在一生中产生超过 70 万加元的卫生系统成本。我们还发现,BPD 患者的平均预期寿命略低于一般人群,并且由于主要并发症而导致的质量调整生命年显著减少。根据 BPD 的严重程度,医疗保健的利用和生活质量的衡量标准有很大差异,这表明对于那些可以预防或减轻 BPD 对患者影响的干预措施,存在着显著的治疗空间。

结论

我们的研究通过根据关键患者特征提出 BPD 的终身负担,对现有证据进行了重要扩展。鉴于生命早期极高的成本负担以及对生活质量的终身负面影响,与目前可用的投资相比,在预防和减轻严重 BPD 方面有更大的空间。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84ae/7093972/9864e3da9027/12887_2020_2037_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84ae/7093972/c153dd3de561/12887_2020_2037_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84ae/7093972/7998ca16b875/12887_2020_2037_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84ae/7093972/9864e3da9027/12887_2020_2037_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84ae/7093972/c153dd3de561/12887_2020_2037_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84ae/7093972/7998ca16b875/12887_2020_2037_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/84ae/7093972/9864e3da9027/12887_2020_2037_Fig3_HTML.jpg

相似文献

1
Lifetime patient outcomes and healthcare utilization for Bronchopulmonary dysplasia (BPD) and extreme preterm infants: a microsimulation study.支气管肺发育不良(BPD)和极早产儿患者的终生预后和医疗保健利用:一项微观模拟研究。
BMC Pediatr. 2020 Mar 25;20(1):136. doi: 10.1186/s12887-020-02037-5.
2
The economic impact of prematurity and bronchopulmonary dysplasia.早产儿和支气管肺发育不良的经济学影响。
Eur J Pediatr. 2017 Dec;176(12):1587-1593. doi: 10.1007/s00431-017-3009-6. Epub 2017 Sep 9.
3
The clinical burden of extremely preterm birth in a large medical records database in the United States: complications, medication use, and healthcare resource utilization.美国一个大型医疗记录数据库中极早产的临床负担:并发症、药物使用及医疗资源利用情况
J Matern Fetal Neonatal Med. 2022 Dec;35(26):10271-10278. doi: 10.1080/14767058.2022.2122035. Epub 2022 Sep 28.
4
Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.吸入或滴注类固醇用于预防支气管肺发育不良。
Neonatology. 2015;107(4):358-9. doi: 10.1159/000381132. Epub 2015 Jun 5.
5
[Influencing factors for the development and severity of bronchopulmonary dysplasia in preterm infants with a gestational age of <32 weeks and a birth weight of <1 500 g].[胎龄<32周且出生体重<1500g的早产儿支气管肺发育不良发生及严重程度的影响因素]
Zhongguo Dang Dai Er Ke Za Zhi. 2022 Dec 15;24(12):1326-1333. doi: 10.7499/j.issn.1008-8830.2207013.
6
Neurodevelopmental outcomes in very preterm infants: The role of severity of Bronchopulmonary Dysplasia.极早产儿的神经发育结局:支气管肺发育不良严重程度的作用。
Early Hum Dev. 2021 Jan;152:105275. doi: 10.1016/j.earlhumdev.2020.105275. Epub 2020 Nov 16.
7
Prevalence of chronic respiratory morbidity, length of stay, inpatient readmissions, and costs among extremely preterm infants with bronchopulmonary dysplasia.支气管肺发育不良的极早产儿中慢性呼吸道疾病的患病率、住院时间、再次入院情况及费用
Expert Rev Pharmacoecon Outcomes Res. 2021 Oct;21(5):1117-1125. doi: 10.1080/14737167.2021.1848554. Epub 2020 Dec 4.
8
[Clinical features and prognosis of preterm infants with varying degrees of bronchopulmonary dysplasia].不同程度支气管肺发育不良早产儿的临床特征及预后
Zhongguo Dang Dai Er Ke Za Zhi. 2018 Apr;20(4):261-266. doi: 10.7499/j.issn.1008-8830.2018.04.002.
9
Characteristics of infants or children presenting to outpatient bronchopulmonary dysplasia clinics in the United States.美国门诊支气管肺发育不良诊所就诊的婴儿或儿童的特征。
Pediatr Pulmonol. 2021 Jun;56(6):1617-1625. doi: 10.1002/ppul.25332. Epub 2021 Mar 13.
10
Respiratory morbidity, healthcare resource use, and cost burden associated with extremely preterm birth in The Netherlands.荷兰极早产儿相关的呼吸系统发病率、医疗资源利用和费用负担。
J Med Econ. 2021 Jan-Dec;24(1):1290-1298. doi: 10.1080/13696998.2021.1999664.

引用本文的文献

1
Pulmonary and neurobehavioral efficacies of AVR-48, a TLR4 modulator, in a preterm lamb model of bronchopulmonary dysplasia.TLR4调节剂AVR-48在支气管肺发育不良早产羔羊模型中的肺和神经行为疗效
Respir Res. 2025 Aug 25;26(1):261. doi: 10.1186/s12931-025-03337-z.
2
The Role of Mesenchymal Stromal Cells in the Treatment of Bronchopulmonary Dysplasia: A Multi-Prong Approach for a Heterogeneous Disease.间充质基质细胞在支气管肺发育不良治疗中的作用:针对一种异质性疾病的多管齐下方法
Compr Physiol. 2025 Aug;15(4):e70038. doi: 10.1002/cph4.70038.
3
Assessing the socio-economic burden of inherited and inflammatory neuromuscular diseases (BIND study): a study protocol.

本文引用的文献

1
Health Care and Societal Costs of Bronchopulmonary Dysplasia.支气管肺发育不良的医疗保健及社会成本
Neoreviews. 2018 Apr;19(4):e211-e223. doi: 10.1542/neo.19-4-e211.
2
The economic impact of prematurity and bronchopulmonary dysplasia.早产儿和支气管肺发育不良的经济学影响。
Eur J Pediatr. 2017 Dec;176(12):1587-1593. doi: 10.1007/s00431-017-3009-6. Epub 2017 Sep 9.
3
Cost Effectiveness of First-Line Oral Therapies for Pulmonary Arterial Hypertension: A Modelling Study.肺动脉高压一线口服疗法的成本效益:一项建模研究。
评估遗传性和炎性神经肌肉疾病的社会经济负担(BIND研究):一项研究方案。
Orphanet J Rare Dis. 2025 Aug 6;20(1):404. doi: 10.1186/s13023-025-03904-z.
4
Multicentre online registration of bronchopulmonary dysplasia in very preterm infants in China: protocol for a prospective, open, observational cohort study.中国极早产儿支气管肺发育不良的多中心在线注册:一项前瞻性、开放、观察性队列研究方案。
BMJ Open. 2024 Nov 24;14(11):e085560. doi: 10.1136/bmjopen-2024-085560.
5
Association between early metabolic acidosis and bronchopulmonary dysplasia/death in preterm infants born at less than 28 weeks' gestation: an observational cohort study.早发性代谢性酸中毒与 28 周以下早产儿支气管肺发育不良/死亡的相关性:一项观察性队列研究。
BMC Pediatr. 2024 Sep 28;24(1):605. doi: 10.1186/s12887-024-05077-3.
6
Association between colonization and bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis.早产儿定植与支气管肺发育不良之间的关联:一项系统评价和荟萃分析。
Front Pediatr. 2024 Aug 8;12:1436568. doi: 10.3389/fped.2024.1436568. eCollection 2024.
7
[Risk factors for bronchopulmonary dysplasia in twin preterm infants: a multicenter study].[双胎早产儿支气管肺发育不良的危险因素:一项多中心研究]
Zhongguo Dang Dai Er Ke Za Zhi. 2024 Jun 15;26(6):611-618. doi: 10.7499/j.issn.1008-8830.2312005.
8
Association between viral infection and bronchopulmonary dysplasia in preterm infants: a systematic review and meta-analysis.病毒感染与早产儿支气管肺发育不良的关系:系统评价和荟萃分析。
Eur J Pediatr. 2024 Jul;183(7):2965-2981. doi: 10.1007/s00431-024-05565-9. Epub 2024 Apr 18.
9
Phthalate exposure in the neonatal intensive care unit is associated with development of bronchopulmonary dysplasia.在新生儿重症监护病房中接触邻苯二甲酸盐与支气管肺发育不良的发生有关。
Environ Int. 2023 Aug;178:108117. doi: 10.1016/j.envint.2023.108117. Epub 2023 Jul 26.
10
Health Care Utilization During the COVID-19 Pandemic Among Individuals Born Preterm.COVID-19 大流行期间早产儿出生人群的医疗保健利用情况。
JAMA Netw Open. 2023 Apr 3;6(4):e2310696. doi: 10.1001/jamanetworkopen.2023.10696.
Pharmacoeconomics. 2016 May;34(5):509-20. doi: 10.1007/s40273-015-0366-8.
4
The Natural History of Bronchopulmonary Dysplasia: The Case for Primary Prevention.支气管肺发育不良的自然史:一级预防的理由
Clin Perinatol. 2015 Dec;42(4):911-31. doi: 10.1016/j.clp.2015.08.014. Epub 2015 Oct 1.
5
Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012.1993 - 2012年极早产儿的护理实践、发病率及死亡率趋势
JAMA. 2015 Sep 8;314(10):1039-51. doi: 10.1001/jama.2015.10244.
6
Impact of diabetes on healthcare costs in a population-based cohort: a cost analysis.基于人群队列研究的糖尿病对医疗费用的影响:一项成本分析。
Diabet Med. 2016 Mar;33(3):395-403. doi: 10.1111/dme.12858. Epub 2015 Aug 19.
7
The economic burden of prematurity in Canada.加拿大早产儿的经济负担。
BMC Pediatr. 2014 Apr 5;14:93. doi: 10.1186/1471-2431-14-93.
8
Patterns and costs of health care use of children with medical complexity.儿童医疗复杂性患者的医疗保健使用模式和费用。
Pediatrics. 2012 Dec;130(6):e1463-70. doi: 10.1542/peds.2012-0175. Epub 2012 Nov 26.
9
Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-5.动态传播建模:ISPOR-SMDM 建模良好实践工作组第 5 工作组报告。
Med Decis Making. 2012 Sep-Oct;32(5):712-21. doi: 10.1177/0272989X12454578.
10
Predictors of bronchopulmonary dysplasia.支气管肺发育不良的预测因素。
Clin Perinatol. 2012 Sep;39(3):585-601. doi: 10.1016/j.clp.2012.06.014.